Immix Biopharma (IMMX) Non-Current Assets (2020 - 2026)
Immix Biopharma's Non-Current Assets was $5.32 million in Q2 2026, up 60.7% from $3.31 million a year earlier and up 50.2% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Immix Biopharma came in at $3.6 million, up 31.0% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 245.1% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $2.75 million in FY2024, $137,410 in FY2023, $10,284 in FY2022 (+80.6%) and $5,695 in FY2021 (-22.6%).
- The Q2 2026 figure marks the highest quarterly Non-Current Assets in data going back to Q4 2020.
- Compared with a year earlier, Non-Current Assets has increased for six straight quarters, with growth averaging 64.9% over the last six quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q1 2024 (growth of 703.8%); the worst was Q4 2021 (a decline of 22.6%).
- Per Business Quant data, IMMX's Non-Current Assets in the three quarters before Q2 2026 was $3.54 million (Q1 2026), $3.6 million (Q4 2025) and $3.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Immix Biopharma | 820.51 Mn | 820.51 Mn | - | 5.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.32 Mn |
| Mar 31, 2026 | 3.54 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 137,410.00 |
| Sep 30, 2023 | 143,271.00 |
| Jun 30, 2023 | 59,273.00 |
| Mar 31, 2023 | 178,186.00 |
| Dec 31, 2022 | 10,284.00 |
| Sep 30, 2022 | 4,126.00 |
| Jun 30, 2022 | 4,691.00 |
| Mar 31, 2022 | 5,075.00 |
| Dec 31, 2021 | 5,695.00 |
| Dec 31, 2020 | 7,361.00 |
API Access
Immix Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();